Instructional Course Lectures: ICL Volume 71 Print + Ebook with Multimedia(AAOS)

Title of the Book

▶ Click Image or Title to the Page on the Site

Instructional Course Lectures: ICL Volume 71 Print + Ebook with Multimedia(AAOS)

Product details

 

도서명: Instructional Course Lectures: ICL Volume 71 Print + Ebook with Multimedia(AAOS)

저 자: Eric J Strauss MD

출판사: AAOS

ISBN : 9781975189860

출판일: 2022.04

판 형: Hardcover

판 수: 71/e

면 수: 528 pages

 

Description

 

Developed in partnership with the American Academy of Orthopaedic Surgeons (AAOS) and edited by Eric J.

Strauss, MD, FAAOS (editor) and Brian J. Galinat, MD, MBA, FAAOS (assistant editor), Instructional Course

Lectures, Volume 71 offers solutions for the most current issues and challenges faced at all stages of your

career. Filled with current, clinically relevant presentations and approaches, the book broadens your

treatment options with experience-based solutions from today’s most respected surgeons and specialty

experts.

ㆍ　Based on selected Instructional Course Lectures presented at the AAOS Annual Meeting 2021 in San Diego

ㆍ　Lead innovation and raise the standard of care in your operating room with new techniques and proven

practical approaches.

ㆍ　Expand and refresh your general orthopaedic, specialty, and practice knowledge

ㆍ　Learn new approaches and surgical techniques from thought leaders

ㆍ　Update your action plans for rehabilitative care with expert insights

ㆍ　Review new techniques for solving the tough challenges you encounter in your practice every day

ㆍ　Chapters are abundantly illustrated with radiographs, drawings, and intraoperative photographs. Some

chapters are enhanced with video that bring the techniques to life.

​

Table of Contents

 

1. SECTION 1: Adult Reconstruction: Hip and Knee

2. 1 Extensile Acetabular Exposure for the Direct Anterior Approach to the Hip

3. Introduction

4. Indications

5. Patient Positioning and Draping

6. Surgical Technique

7. Acetabular Implant Exposure

8. Intrapelvic Exposure

9. Closure

10. Practical Examples

11. Summary

12. References

13. 2 Extensile Femoral Exposure for the Direct Anterior Approach to the Hip

14. Introduction

15. Indications

16. Patient Positioning and Draping

17. Surgical Technique

18. Incision and Subcutaneous Dissection

19. Extension of the Approach Distally

20. Femoral Releases for Improved Access of the Femur

21. Special Situations

22. Implant Removal

23. Trochanteric Osteotomy

24. Proximal Femoral Replacement

25. Closure

26. Summary

27. Acknowledgment

28. References

29. 3 Management of Severe Acetabular Bone Loss With Chronic Pelvic Discontinuity in Revision Total Hip Arthroplasty

30. Introduction

31. Preoperative and Intraoperative Identification of a Chronic Pelvic Discontinuity

32. Noncemented Treatment Options for Chronic Pelvic Discontinuity

33. Cup-Cage Reconstruction

34. Custom Triflange Acetabular Implant Reconstruction

35. Custom 3D-Printed Acetabular Implants

36. Acetabular Distraction Technique With Modular Porous Metal Augments

37. Summary

38. References

39. 4 Tough Questions in Total Hip and Total Knee Arthroplasty

40. Introduction

41. Preoperative Questions

42. Obesity: Is There an Absolute Cutoff?

43. Should Smoking Cessation Be Mandated For All Patients?

44. What Is the Most Accurate Predictor of Diabetic Control?

45. Which Patients Are Candidates for Outpatient Arthroplasty?

46. Perioperative Questions

47. When Should a First-Generation Cephalosporin for Prophylaxis Not Be Used?

48. Should Vancomycin Powder Be Used Topically?

49. Are There Any Contraindications to Tranexamic Acid in 2021?

50. When Should Negative-Pressure Dressings Be Used in Primary Arthroplasty?

51. Are Local Injections Effective?

52. If Bilateral Procedures Are Staged, What Is the Appropriate Interval?

53. Postoperative Questions

54. Is Formal Postoperative Physical Therapy Necessary?

55. When Can Patients Resume Driving After Arthroplasty?

56. Should Patients Be Advised Not to Return to High-Level Sporting Activity After Hip or Knee Arthroplasty?

57. How Long Should Patients Be Advised to Undergo Dental Prophylaxis?

58. Summary

59. References

60. 5 Outpatient Joint Arthroplasty: Practical Guidelines for Success, Effect of COVID-19, and the Roles of Technology and Partnering With Industry

61. Introduction

62. Trends in Outpatient Joint Arthroplasty

63. COVID-19 and Outpatient Joint Arthroplasty

64. Prepandemic Ambulatory Arthroplasty Program

65. Postpandemic Modifications

66. Anesthesia Relationships and Outpatient Protocols

67. Anesthesia Relationships

68. Establishing Protocols

69. Barriers to Discharge

70. Patient/Family Choice

71. Pain

72. Nausea

73. Dizziness/Hypotension

74. Ambulation

75. Urinary Retention

76. Technology, Industry Partners, and Contracting in Outpatient Joint Arthroplasty

77. Technology Facilitating Discharge

78. Benefits of Telehealth Rehabilitation

79. Technology in ASCs

80. Partnering With Vendors/Industry

81. Contracting

82. Summary

83. References

84. 6 Preoperative Optimization Before Elective Total Joint Replacement

85. Introduction

86. Weight Loss

87. Nutritional Assessment and Treatment

88. Glucose Control

89. Cardiac Concerns

90. Pulmonary Disease

91. Urinary Tract Infection

92. Lymphedema

93. Dental Screening

94. Renal Disease

95. Summary

96. References

97. 7 Perioperative Blood Management in Total Joint Arthroplasty

98. Introduction

99. Preoperative Anemia

100. Background

101. Diagnosis and Treatment

102. Erythropoietin

103. Type and Screen

104. Tranexamic Acid

105. Aminocaproic Acid

106. Transfusion

107. Transfusion Criteria

108. Intraoperative Cell Salvage

109. Drains

110. Autologous Blood Donation

111. Leukoreduced Blood

112. Bleeding and Clotting Disorders; Blood-Thinning Agents

113. Human Immunodeficiency Virus

114. Summary

115. References

116. 8 Often Overlooked Modifiable Risk Factors Before Total Joint Replacement

117. Introduction

118. Medications to Stop

119. Smoking—Nicotine (Cigarettes and Patches), Vaping, Marijuana

120. Alcohol Use

121. Substance Use Disorder

122. Psychiatric Disorders

123. Multiple Allergies

124. Fibromyalgia

125. Chronic Opioid Use

126. Summary

127. References

128. 9 Periprosthetic Infections: Five Steps to Keep Moving Forward in 2021

129. Introduction

130. Step 1: It is Time to Include a Value Proposition in PJI Diagnosis

131. Step 2: It is Time for a Personalized Approach to Estimate PJI Risk and Prevent It

132. Step 3: PJI Treatment Requires Expertise: Patients Should Be Concentrated in Superspecialized Units

133. Step 4: The Success of Different Treatment Strategies Has to Be Measured With a Uniform Definition

134. Step 5: Benchmark Studies in Contemporary Results for One-Stage and Two-Stage Revision Are Needed

135. Summary

136. References

137. 10 Antibiotic Prophylaxis for Total Joint Arthroplasty

138. Introduction

139. Historical Background

140. Goals of Prophylaxis

141. Overview of Current Guidelines

142. Choice of Prophylactic Agents

143. Timing and Duration of Prophylaxis

144. Summary

145. References

146. SECTION 2: General Orthopaedics

147. 11 Nonsurgical Management of Osteoarthritis of the Knee: What You Should Be Injecting Now and in the Future

148. Introduction

149. Triamcinolone Acetonide Extended-Release

150. Hyaluronic Acid: Science, Controversy, and Current Role

151. The Role of Injectable Biologics: Platelet-Rich Plasma and Stem Cells

152. Platelet-Rich Plasma

153. Bone Marrow Aspirate Concentrate

154. Adipose-Derived SVF

155. Summary

156. References

157. 12 Nonarthroplasty Management of Shoulder Arthritis in the Aging Athlete: Biologics and Arthroscopy

158. Introduction

159. Nonsurgical Management

160. Activity Modification and Pain Management

161. Physical Therapy

162. Injection Therapy With Corticosteroid or Hyaluronic Acid

163. Injectable Biologics (PRP, Stem Cells)

164. Nonarthroplasty Surgical Management of Glenohumeral Osteoarthritis

165. Surgical Decision Making

166. Shoulder Arthroscopy

167. Management of Focal Cartilage Defects (Microfracture)

168. Glenoid Resurfacing (Experimental)

169. Autologous Chondrocyte Implantation and Fresh OCA Transplantation

170. Summary

171. References

172. SECTION 3: Hand and Wrist

173. 13 Managing Challenges in Thumb Carpometacarpal Arthritis

174. Introduction

175. Radiographic Classification

176. Anatomy and Pathoanatomy

177. Laxity, Proprioception, and Functional Demands

178. Trapezium-Sparing Procedures

179. Extension Osteotomy

180. Arthrodesis

181. Tenotomy, Fat Interposition, Synovectomy, and Denervation

182. Nonimplant Trapezial Resection Procedures

183. Trapeziectomy Alone

184. Distraction Hematoma Arthroplasty

185. Interposition Arthroplasty

186. Ligament Reconstruction With or Without Interposition

187. Arthroscopy

188. Implant Arthroplasty Procedures

189. Interposition

190. Hemiarthroplasty/Total Joint Arthroplasty

191. Indications and Contraindications

192. Technical Considerations

193. Outcomes

194. Literature Review

195. Management of Early-Stage (I and II) Thumb CMC Arthritis

196. Management of Moderate-Stage (II and III) Thumb CMC Arthritis

197. Management of Severe Stage (IV) Thumb CMC Arthritis

198. Summary

199. References

200. 14 Tips and Tricks in the Management of Distal Radius Fractures

201. Introduction

202. Distal Radius Volar Plating

203. Challenge 1: Choosing the Right Indication

204. Challenge 2: The Unstable Radial Column

205. Challenge 3: The Comminuted Lunate Fossa

206. Challenge 4: The Volar Marginal Fragment

207. Challenge 5: The Inveterate Fracture

208. Challenge 6: Central Articular Impaction

209. Challenge 7: Radial Shift

210. Challenge 8: Plate Selection

211. Challenge 9: The Unstable DRUJ

212. External Fixation

213. Nonsurgical Management

214. Surgical Management

215. The Importance of Wrist Position for Digital Function

216. Recommended Technique

217. Further Comparison With Open Reduction and Internal Fixation

218. The Things That Should be Remembered But are Forgotten: The Management of Concomitant and Associated Injuries With Distal Radius Fractures

219. Scapholunate Ligament Injuries

220. DRUJ Instability and TFCC Pathology

221. EPL Rupture

222. Summary

223. References

224. SECTION 4: Musculoskeletal Oncology

225. 15 Evolution of Surgical Management of Metastatic Disease of the Pelvis

226. Introduction

227. Patient Assessment

228. History of Pelvic Surgery

229. Anatomic Location and Classification Systems

230. Indications

231. Imaging

232. Preoperative Planning

233. Harrington Reconstruction Method

234. Minimally Invasive Options

235. Cryotherapy

236. Radiofrequency Ablation

237. Microwave Ablation

238. MRI-Guided High-Intensity Focused Ultrasound Ablation

239. Acetabuloplasty/Percutaneous Cementoplasty

240. Harrington 0 to I or MAC 1

241. Harrington II or MAC 2

242. Harrington III or MAC 3

243. Harrington IV or MAC 4

244. Custom Prosthesis

245. Summary

246. References

247. 16 Local Control of Cancers With Various Ablation Techniques

248. Introduction

249. Patient Selection

250. Imaging Options and Considerations

251. Ablative Modalities

252. Soft-Tissue Disease

253. Procedural Workflow

254. Patient Positioning

255. Cone-Beam CT Scan

256. Ablation

257. Cementation

258. Postoperative Course

259. Complications

260. Case Examples

261. Case 1

262. Case 2

263. Case 3

264. Case 4

265. Case 5

266. Discussion

267. Future Directions

268. Summary

269. References

270. 17 Ablation, Osteoplasty, Reinforcement, and Internal Fixation as a New Alternative First-Line Management for Osteolytic Pelvic Metastases

271. Introduction

272. Rationale for AORIF

273. Oncologic Considerations

274. Biomechanical Considerations

275. Biologic Considerations

276. Pain Control Perspectives

277. Early Ambulation and Muscle Strengthening

278. Indications

279. Approach

280. Imaging

281. Ablation

282. Balloon Osteoplasty

283. PMMA Bone Cementoplasty

284. Internal Fixation

285. Limitations of AORIF and Other Percutaneous Procedures

286. Summary

287. References

288. 18 Fluoroscopic Percutaneous Fixation of Periacetabular Metastatic Cancer: The Tripod Technique

289. Introduction

290. Indications

291. Preoperative Preparations

292. Surgical Techniques

293. Positioning

294. General Surgical Procedure

295. Anterior Column Screw

296. Posterior Column Screw

297. Transcolumnar Screw

298. Conversion to THA

299. Modification of the Tripod Construct

300. Adaptation to Manage Non-periacetabular Lesions

301. Tips and Tricks

302. Postoperative Care

303. Discussion

304. Summary

305. References

306. 19 Tumors and Tumorlike Conditions of Which Every Orthopaedic Surgeon Should Be Aware

307. Introduction

308. The General Orthopaedic and Trauma Practices

309. Workup

310. Surgical Principles

311. Trauma and Musculoskeletal Oncology

312. Orthopaedic Oncology in the Setting of Pediatrics

313. Benign Pediatric Bone Tumors

314. Benign-Aggressive and Malignant Pediatric Bone Tumors

315. The Sports and Arthroplasty Practices

316. Clinical Presentation

317. Enchondroma

318. Baker Cyst

319. Enostosis

320. Synovial Chondromatosis

321. Tenosynovial Giant Cell Tumor

322. Osteolysis

323. Pseudotumor

324. Osteonecrosis

325. Multiple Hereditary Exostoses

326. Paget Disease

327. Sarcoma

328. The Spine Practice: Staying Out of Trouble With Tumors

329. General Approach to Spine Tumors

330. Spine Tumor Mimics

331. Benign, Quiescent Conditions

332. Metastatic Spinal Disease

333. Primary Spinal Malignancies

334. Summary

335. References

336. SECTION 5: Pediatrics

337. 20 Lower Limb Deformity Correction: Analysis and Preoperative Planning

338. Introduction

339. Deformity Analysis of the Lower Extremity

340. Preoperative Planning: Hexapod External Fixation

341. Case Presentation

342. Preoperative Planning: Plate Fixation

343. Case Presentation

344. Preoperative Planning: Intramedullary Nail Fixation

345. Case Presentation

346. Pearls and Pitfalls

347. Additional Considerations

348. Summary

349. References

350. 21 Limb Reconstruction After Premature Growth Arrest Secondary to Bone Infections

351. Introduction

352. Risk Factors for Sequelae

353. Delayed Diagnosis

354. Wrong or Insufficient Treatment

355. Newborns

356. Infection Caused by Panton-Valentine Leukocidin S aureus

357. Pathophysiology of Sequelae

358. Evaluation of a Physeal Bar

359. Predicting LLD

360. Treatment Strategies

361. Regenerative Therapies

362. Physeal Preservation Techniques

363. Physeal Distraction

364. Management of Sequelae

365. Summary

366. References

367. SECTION 6: Trauma

368. 22 Do All Fractures Need Surgery?

369. Introduction

370. Ankle Fractures

371. Treatment Principles

372. Isolated Malleolar Fractures

373. Isolated Lateral Malleolus Fractures

374. Bimalleolar and Trimalleolar Fractures

375. Proximal Humerus Fractures in Patients Older Than 60 Years

376. Treatment Principles

377. Nonsurgical Treatment Outcomes

378. Surgical Treatment: Is It Too Aggressive?

379. Trends and Proposed Treatment Algorithm

380. Humeral Shaft Fractures in Young, Active Patients

381. Treatment Principles

382. Nonsurgical Treatment

383. Comparative Results and Outcomes

384. Distal Radius Fractures in the Elderly

385. Treatment Principles

386. Trends

387. Is Treatment Too Aggressive?

388. Limitations

389. Key Takeaways

390. Summary

391. References

392. 23 Forearm Fractures: Diagnosis and Contemporary Treatment Strategies

393. Introduction

394. Epidemiology

395. Assessment

396. Initial Management

397. Principles of Treatment

398. Classification of Diaphyseal Forearm Fractures

399. Radial Shaft Fractures

400. Management

401. Outcomes

402. Ulnar Shaft Fractures

403. Management

404. Outcomes

405. Both-Bone Forearm Fractures

406. Initial Assessment

407. Management

408. Outcomes

409. Galeazzi Injuries

410. Classification System

411. Management

412. Outcomes

413. Monteggia Fracture-Dislocations

414. Classification

415. Management

416. Outcomes

417. Summary

418. References

419. 24 Elbow Trauma: An Evidence-Based Approach to Improving Outcomes

420. Introduction

421. DHFs: Evidence-Based Management

422. Radial Head/Neck Fractures: When and How to Fix or Replace

423. Olecranon Fractures: An Approach for Injuries From Simple to Extreme

424. Terrible Triad Injuries: How to Improve Outcomes

425. Coronoid Fractures: When and How to Fix Them

426. Elbow Dislocations: Tips and Tricks to Improve Outcomes

427. Managing Complications in Elbow Fracture Surgery

428. Monteggia Injury

429. Ulnar Neuropathy

430. Stiffness

431. Nonunion

432. Summary

433. References

434. 25 Augmentation of Fracture Repair: Is Anything Ready for Prime Time?

435. Introduction

436. Universal Use of Antibiotic Powder in Open Wounds: Do the Benefits Outweigh the Risks?

437. RIA for Autograft: Should This Be Always Used or Is There Still a Role for the Iliac Crest?

438. What Role Does Allograft Play in Fracture Management?

439. Cell-Based Therapies for Fracture Repair: Is the Evidence Strong Enough for Routine Use?

440. Is There Any Role for BMPs and Osteoinductive Proteins?

441. An Evidence-Based Approach to the Management of Nonunion With No Bone Defect

442. An Evidence-Based Approach to the Management of Nonunion With a Bone Defect

443. Summary

444. References

445. SECTION 7: Shoulder and Elbow

446. 26 Shoulder Arthroplasty in the Aging Athlete: Considerations in the Younger Patient

447. Introduction

448. General Considerations

449. Patient Evaluation

450. Diagnoses

451. Hemiarthroplasty

452. Hemiarthroplasty With Ream and Run

453. Hemiarthroplasty With Biologic Resurfacing

454. Stemless Total Shoulder Arthroplasty

455. Resurfacing Prosthesis

456. Partial Resurfacing Prosthesis

457. Anatomic Total Shoulder Arthroplasty

458. Reverse Total Shoulder Arthroplasty

459. Postoperative Rehabilitation Protocol

460. Summary

461. References

462. 27 New Approaches to the Diagnosis and Management of Periprosthetic Joint Infection of the Shoulder

463. Introduction

464. Evaluation of PJI of the Shoulder: Development of a New Diagnostic Criteria and Its Application

465. Diagnostic Testing

466. Definition of Shoulder PJI

467. Cutibacterium and the Failed Shoulder Arthroplasty

468. Treatment Strategies for PJI of the Shoulder: Antibiotics, One-Stage Versus Two-Stage Revision, and What to Do With Delayed, Unexpected Positive Cultures

469. Prevention

470. Antibiotics Alone

471. Irrigation and Débridement With Implant Retention

472. One-Stage and Two-Stage Revision Arthroplasty

473. Permanent Antibiotic Spacer

474. Resection Arthroplasty

475. Unexpected Positive Cultures

476. Reconstructive Options for PJI of the Shoulder

477. Glenoid Bony Defects

478. Humeral Bony Defects

479. Summary

480. References

481. 28 Stemless Shoulder Arthroplasty

482. Introduction

483. Stemless Humeral Implants in Anatomic TSA

484. Stemless Humeral Implants in Reverse TSA

485. Summary

486. References

487. SECTION 8: Spine

488. 29 Is It the Back or the Hip? Differentiating Lumbar Spine From Hip Pathologies: Key Points of Evaluation and Treatment

489. Introduction

490. The Incidence and Likely Etiology of Concurrent Hip and Spine Pathology

491. Clinical Presentation

492. History

493. Physical Examination

494. Differential Diagnosis

495. Imaging and Radiologic Workup

496. Nonsurgical Management

497. Surgical Intervention

498. Outcomes Following Surgery for Patients With HSS

499. Summary

500. References

501. 30 Navigation Options for Spinal Surgeons: State of the Art 2021

502. Introduction

503. 3D Image-Based CAN

504. Robot-Assisted Navigation

505. 3D-Printed Patient-Specific Drill Guides

506. Radiation Considerations

507. Radiation From CT and Enabling Technologies

508. Intraoperative CT-Guided Navigation Compared With Fluoroscopy

509. Operating Room Personnel Exposure

510. Effect of Navigation on Education for Trainees

511. Safety and Economic Considerations With Navigation

512. Summary

513. References

514. 31 Vertebral Body Tethering: Rationale, Results, and Revision

515. Introduction

516. Indications and Patient Selection

517. Surgical Approach and Thoracoscopic Technique Considerations

518. Anesthesia and Positioning

519. Thoracoscopic Approach

520. Minithoracotomy With Thoracoscopic Assistance

521. Approach for Thoracolumbar/Lumbar Curves

522. Perioperative Care

523. Clinical Outcomes

524. Complications

525. Future Directions

526. Summary

527. References

528. 32 Achieving Lumbar Fusion: An Evidence-Based Approach to Selecting Technique, Implants, and Biologics

529. Introduction

530. Approach to Achieving Fusion: Which Technique Is the Best?

531. Interbody Cages: Which Material Is the Best?

532. Bone Graft Choices: Autograft, Allograft, and Bone Graft Extenders

533. Bone Morphogenetic Protein

534. Cellular-Based Allografts

535. Osteoporosis in Spine Surgery

536. Summary

537. References

538. 33 Update on the Diagnosis and Management of Spinal Infections

539. Introduction

540. Etiopathogenesis

541. Clinical Presentation

542. Laboratory Evaluation

543. Imaging Studies

544. Treatment

545. Nonsurgical Treatment

546. Surgical Treatment

547. Epidural Abscess

548. Prognosis

549. Summary

550. References

551. SECTION 9: Foot and Ankle

552. 34 Chronic Achilles Tendon Ruptures: From Bracing Treatment to Complex Reconstruction

553. Introduction

554. Clinical Presentation

555. Imaging

556. Nonsurgical Treatment

557. Muscle and Tendon Structure and Function

558. Treatment Options

559. Management of Chronic Achilles Tendon Ruptures With Local Tissue Procedures

560. Achilles Tendon Repair Using Native Achilles Tissue

561. Management of Chronic Achilles Tendon Ruptures Using Graft Reconstruction

562. Allograft Reconstruction for Chronic Achilles Tendon Ruptures

563. Management of Chronic Achilles Tendon Ruptures Using Tendon Transfers

564. Summary

565. References\

566. SECTION 10: Sports Medicine

567. 35 Surgical Considerations in Revision Anterior Cruciate Ligament Reconstruction

568. Introduction

569. Epidemiology

570. Preoperative Evaluation

571. Etiology

572. Tunnel Placement

573. Concomitant Ligamentous Laxity

574. Concomitant Meniscal Pathology

575. Malalignment

576. Indications and Patient Selection

577. Surgical Considerations

578. Staging

579. Tunnel Placement

580. Graft Choice

581. Anterolateral Ligament Reconstruction or LET

582. Postoperative Rehabilitation

583. Outcomes

584. Summary

585. References

586. 36 Postoperative Infection After Anterior Cruciate Ligament Reconstruction: Prevention and Management

587. Introduction

588. Infection Prevention Strategies

589. Tobacco Cessation

590. Prophylactic Intravenous Antibiotics

591. Drain Use

592. Graft Choice

593. Clinical Pathways

594. Gentamicin Irrigation/Graft Presoaking

595. Vancomycin Graft Presoaking

596. Management of ACL Infection

597. Diagnosis

598. Arthroscopic Irrigation

599. The Importance of Graft Retention

600. Authors’ Experience

601. Summary

602. References

603. Index

 

▶ Click Here( https://www.medcore.kr )to Homepage

 

---

 

Instructional Course Lectures: ICL Volume 71 Print + Ebook with Multimedia(AAOS)